Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:3:p2
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 3 (pt 2/8)
Character Range: 163238–166092

of acute pain due to primary dysmenorrhea or musculoskeletal or soft tissue injuries in adults.
CHLORAMPHENICOL for ophthalmic use only.
CHLORBUTANOL in preparations for human use except:
 (a) when included in Schedule 2; or
 (b) in preparations containing 0.5% or less of chlorbutanol.
CHLORPHENAMINE in oral preparations except:
 (a) when included in Schedule 2; or
 (b) for the treatment of children under 2 years of age.
CICLOPIROX in preparations for dermal use and for application to the nails except:
 (a) when included in Schedule 2; or
 (b) in preparations for the treatment of tinea pedis.
CIMETIDINE in a primary pack containing not more than 14 days' supply.
CLEMASTINE in preparations for oral use.
CLOBETASONE (clobetasone‑17‑butyrate) as the only therapeutically active substance in preparations for dermal use containing 0.05% or less of clobetasone in packs containing 30 g or less of the preparation.
CLOTRIMAZOLE in preparations for vaginal use.
CYCLIZINE in divided preparations for oral use in primary packs containing 6 dosage units or less.
CYPROHEPTADINE in oral preparations.
CYTISINE in divided oral and oromucosal preparations with a recommended daily dose of 9 mg or less of cytisine as an aid in withdrawal from tobacco smoking in adults.
DEXCHLORPHENAMINE in oral preparations except:
 (a) when included in Schedule 2; or
 (b) for the treatment of children under 2 years of age.
DICLOFENAC in divided preparations for oral use containing 25 mg or less of diclofenac per dosage unit in a pack containing 30 or less dosage units except when included in Schedule 2.
DIHYDROCODEINE when indicated for cough suppression and compounded with one or more other therapeutically active substances:
 (a) in divided preparations containing 10 mg or less of dihydrocodeine per dosage unit and with a recommended dose not exceeding 15 mg of dihydrocodeine; or
 (b) in undivided preparations containing 0.25% or less of dihydrocodeine with a recommended dose not exceeding 15 mg of dihydrocodeine.
DIIODOHYDROXYQUINOLINE (iodoquinol) for vaginal use.
DIMENHYDRINATE in oral preparations except when included in Schedule 2.
DIMETHINDENE in oral preparations.
DIPHENHYDRAMINE in oral preparations except:
 (a) when included in Schedule 2; or
 (b) for the treatment of children under 2 years of age.
DIPHENOXYLATE in packs of 8 or less dosage units, each dosage unit containing 2.5 mg or less of diphenoxylate and a quantity of atropine sulfate equivalent to at least 1% of the dose of diphenoxylate.
DITHRANOL for therapeutic use.
DOXYLAMINE in oral preparations except:
 (a) when included in Schedule 2; or
 (b) for the treatment of children under 2 years of age.
ECONAZOLE in preparations for vaginal use.
ELETRIPTAN for oral use in tablets containing 40 mg or less per tablet and when in a pack containing not more than 2 dosage units for